What is the appropriate indication, dosage, contraindications, and monitoring for ferrous sulfate therapy in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferrous Sulfate for Iron Deficiency Anemia in Adults

For treating iron deficiency anemia in adults, start with ferrous sulfate 200 mg (65 mg elemental iron) once daily, taken on an empty stomach in the morning with vitamin C or citrus juice to optimize absorption. 1

Indications

Ferrous sulfate is indicated for:

  • Iron deficiency anemia (IDA) - defined as low hemoglobin with evidence of iron deficiency
  • Treatment should not be delayed while awaiting diagnostic investigations unless colonoscopy is imminent 1

Dosing Strategy

Initial Treatment

  • Standard dose: 50-100 mg elemental iron once daily (e.g., one ferrous sulfate 200 mg tablet = 65 mg elemental iron) 1
  • Timing: Take in the fasting state (morning preferred) for optimal absorption 1, 2
  • With vitamin C: Administer with approximately 100 mg vitamin C or citrus juice to enhance absorption 2

Alternative Dosing for Intolerance

If gastrointestinal side effects occur:

  • Alternate-day dosing: One tablet every other day - this significantly reduces GI side effects (56% reduction in pregnant women) while maintaining similar total hemoglobin response after equivalent total dose 1, 3
  • Alternate-day dosing shows better fractional iron absorption (21.8% vs 16.3% with daily dosing) due to lower hepcidin stimulation 3
  • Do not switch to different iron salts - this practice is not evidence-supported 1

Duration

  • Continue treatment for approximately 3 months after hemoglobin normalizes to replenish iron stores 1
  • Standard ferrous sulfate 200 mg tablets contain 65 mg elemental iron 4

Monitoring Protocol

Early Response Assessment (Critical)

  • Check hemoglobin at 2 weeks: Absence of ≥10 g/L rise is 90.1% sensitive and 79.3% specific for predicting treatment failure 1
  • This early checkpoint identifies non-responders who need alternative therapy (parenteral iron)

Ongoing Monitoring

  • Every 4 weeks until hemoglobin normalizes 1
  • After treatment completion: Monitor blood count every 6 months initially to detect recurrence 1

Causes of Treatment Failure

If inadequate response occurs, consider:

  • Non-compliance (most common)
  • Malabsorption
  • Ongoing blood loss
  • Concurrent vitamin B12 or folate deficiency
  • Systemic inflammatory disease
  • Bone marrow pathology 1

Contraindications & When to Use Parenteral Iron

Switch to parenteral iron when:

  • Oral iron is contraindicated
  • Ineffective (no response at 2 weeks)
  • Not tolerated despite alternate-day dosing 1
  • Chronic disease with ongoing blood loss
  • Impaired GI absorption
  • GI inflammatory pathology 1

Administration Pearls to Optimize Absorption

What ENHANCES absorption:

  • Fasting state (empty stomach)
  • Morning administration
  • Vitamin C (100 mg) or citrus juice
  • Plain water if vitamin C unavailable 2

What IMPAIRS absorption (avoid):

  • Afternoon dosing
  • Food (especially cereals, grains)
  • Milk, tea, coffee
  • Calcium supplements
  • Antacids, H2 blockers, proton pump inhibitors
  • Lying down within 30-60 minutes (risk of pill esophagitis) 2

Common Pitfalls

  1. Prescribing twice-daily dosing: This increases hepcidin and actually reduces absorption while increasing side effects 1, 3

  2. Using modified-release preparations: These are considered less suitable for prescribing 1

  3. Switching between iron salts for intolerance: Not evidence-based; instead use alternate-day dosing or consider ferric maltol or parenteral iron 1

  4. Inadequate monitoring: Missing the 2-week checkpoint delays identification of treatment failure 1

  5. Stopping too early: Must continue 2-3 months after hemoglobin normalizes to replete stores 1

Side Effects & Tolerance

  • Most common: Constipation (33%), heartburn (14%), abdominal pain (13%) 5
  • GI symptoms are dose-dependent: Twice-daily dosing causes significantly more symptoms than once-daily 6, 7
  • Alternate-day dosing reduces side effects by 44% while maintaining efficacy 1

Special Considerations

Blood transfusion is rarely needed for IDA and should be reserved for severe symptomatic anemia or circulatory compromise. If used, target hemoglobin 70-90 g/L (80-100 g/L with unstable coronary disease), then follow with iron replacement 1

The evidence strongly supports that less is more with oral iron - once-daily or alternate-day dosing optimizes the balance between efficacy, absorption, and tolerability compared to traditional multiple-daily-dosing regimens.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.